Jonathan C Roberts
CIK 1410515 · View on SEC EDGAR ↗
Insider
First SEC filing: April 3, 2008 · Latest: April 3, 2008
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 84 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
84 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 27, 2022 | CVS | S 10b5-1 | 68,482 | $107.50 | $7,361,815 | 107,115 Direct | -39.00% | Disposed | -11.0% (price as of 2026-08-19) |
| Nov. 3, 2021 | CVS | S 10b5-1 | 108,870 | $95.00 | $10,342,650 | 107,115 Direct | -50.41% | Disposed | 0.7% (price as of 2026-08-19) |
| March 26, 2021 | CVS | S 10b5-1 | 73,433 | $74.49 | $5,470,024 | 664 Direct | -99.10% | Disposed | 28.4% (price as of 2026-08-19) |
| Jan. 8, 2020 | CVS | S 10b5-1 | 57,563 | $72.63 | $4,180,801 | 45,045 Direct | -56.10% | Disposed | 31.7% (price as of 2026-08-19) |
| Feb. 1, 2019 | CVS | S 10b5-1 | 77,639 | $64.54 | $5,010,821 | 33,764 Direct | -69.69% | Disposed | 48.2% (price as of 2026-08-19) |
| Sept. 18, 2017 | CVS | S 10b5-1 | 85,743 | $83.14 | $7,128,673 | 33,812 Direct | -71.72% | Disposed | 15.0% (price as of 2026-08-19) |
| Feb. 16, 2017 | CVS | S 10b5-1 | 61,196 | $80.00 | $4,895,680 | 28,759 Direct | -68.03% | Disposed | 19.5% (price as of 2026-08-19) |
| Feb. 11, 2016 | CVS | S | 23,355 | $92.86 | $2,168,745 | 28,644 Direct | -44.91% | Disposed | 3.0% (price as of 2026-08-19) |
| Jan. 7, 2015 | CVS | S 10b5-1 | 86,487 | $95.31 | $8,243,076 | 31,468 Direct | -73.32% | Disposed | 0.3% (price as of 2026-08-19) |
| Jan. 2, 2014 | CVS | S 10b5-1 | 101,708 | $70.61 | $7,181,602 | 29,302 Direct | -77.63% | Disposed | 35.4% (price as of 2026-08-19) |
| Jan. 2, 2014 | CVS | S 10b5-1 | 60,484 | $70.61 | $4,270,775 | 29,302 Direct | -67.36% | Disposed | 35.4% (price as of 2026-08-19) |
| Sept. 4, 2012 | CVS | S 10b5-1 | 32,273 | $45.55 | $1,470,035 | 25,819 Direct | -55.55% | Disposed | 109.9% (price as of 2026-08-19) |
| Sept. 4, 2012 | CVS | S 10b5-1 | 32,273 | $45.54 | $1,469,712 | 58,092 Direct | -35.71% | Disposed | 110.0% (price as of 2026-08-19) |
| Sept. 1, 2011 | CVS | S 10b5-1 | 48,000 | $36.01 | $1,728,480 | 18,612 Direct | -72.06% | Disposed | 165.6% (price as of 2026-08-19) |
| Feb. 9, 2011 | CVS | S | 24,000 | $33.40 | $801,600 | 18,549 Direct | -56.41% | Disposed | 186.3% (price as of 2026-08-19) |
| June 17, 2009 | CVS | S | 104,000 | $31.06 | $3,230,240 | 21,849 Direct | -82.64% | Disposed | 207.9% (price as of 2026-08-19) |
Showing latest 100 of 114 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2022 | CVS | Stock Option | Common Stock (25,987) | $101.09 | April 1, 2032 | 25,987 | Acquired |
| Jan. 27, 2022 | CVS | Stock Option | Common Stock (68,482) | $102.26 | April 1, 2022 | 68,482 | Disposed |
| Nov. 3, 2021 | CVS | Stock Option | Common Stock (108,870) | $45.93 | Sept. 4, 2022 | 108,870 | Disposed |
| April 1, 2021 | CVS | Stock Option | Common Stock (172,772) | $74.30 | April 1, 2031 | 172,772 | Acquired |
| March 26, 2021 | CVS | Stock Option | Common Stock (73,433) | $74.29 | April 1, 2021 | 73,433 | Disposed |
| April 1, 2020 | CVS | Stock Option | Common Stock (239,355) | — | April 1, 2030 | 239,355 | Acquired |
| April 1, 2020 | CVS | Stock Option | Common Stock (239,355) | — | April 1, 2030 | 239,355 | Acquired |
| Jan. 8, 2020 | CVS | Stock Option | Common Stock (68,844) | $54.53 | April 1, 2020 | 68,844 | Disposed |
| April 1, 2019 | CVS | Stock Option | Common Stock (303,010) | $54.19 | April 1, 2029 | 303,010 | Acquired |
| Feb. 1, 2019 | CVS | Stock Option | Common Stock (77,639) | $45.07 | April 2, 2019 | 77,639 | Disposed |
| April 1, 2018 | CVS | Stock Option | Common Stock (248,131) | $62.21 | April 1, 2025 | 248,131 | Acquired |
| Sept. 18, 2017 | CVS | Stock Option | Common Stock (85,743) | $34.96 | April 1, 2018 | 85,743 | Disposed |
| April 3, 2017 | CVS | Stock Option | Common Stock (200,358) | $78.05 | April 3, 2024 | 200,358 | Acquired |
| Feb. 16, 2017 | CVS | Stock Option | Common Stock (61,196) | $36.23 | April 1, 2017 | 61,196 | Disposed |
| April 1, 2016 | CVS | Stock Option | Common Stock (161,318) | $104.82 | April 1, 2023 | 161,318 | Acquired |
| April 1, 2015 | CVS | Stock Option | Common Stock (68,482) | $102.26 | April 1, 2022 | 68,482 | Acquired |
| Jan. 7, 2015 | CVS | Stock Option | Common Stock (86,487) | $41.17 | April 1, 2015 | 86,487 | Disposed |
| April 1, 2014 | CVS | Stock Option | Common Stock (73,433) | $74.29 | April 1, 2021 | 73,433 | Acquired |
| Jan. 2, 2014 | CVS | Stock Option | Common Stock (101,708) | $28.10 | April 1, 2016 | 101,708 | Disposed |
| Jan. 2, 2014 | CVS | Stock Option | Common Stock (60,484) | $34.42 | April 2, 2014 | 60,484 | Disposed |
| April 1, 2013 | CVS | Stock Option | Common Stock (68,844) | $54.53 | April 1, 2020 | 68,844 | Acquired |
| Sept. 4, 2012 | CVS | Stock Option | Common Stock (108,870) | $45.93 | Sept. 4, 2022 | 108,870 | Acquired |
| Sept. 4, 2012 | CVS | Stock Option | Common Stock (64,546) | $30.04 | April 3, 2013 | 64,546 | Disposed |
| April 2, 2012 | CVS | Stock Option | Common Stock (77,639) | $45.07 | April 2, 2019 | 77,639 | Acquired |
| Sept. 1, 2011 | CVS | Stock Option | Common Stock (48,000) | $22.44 | Jan. 5, 2012 | 48,000 | Disposed |
| April 1, 2011 | CVS | Stock Option | Common Stock (85,743) | $34.96 | April 1, 2018 | 85,743 | Acquired |
| Feb. 9, 2011 | CVS | Stock Option | Common Stock (24,000) | $30.26 | March 7, 2011 | 24,000 | Disposed |
| April 1, 2010 | CVS | Stock Option | Common Stock (61,196) | $36.23 | April 1, 2017 | 61,196 | Acquired |
| June 17, 2009 | CVS | Stock Option | Common Stock (48,000) | $17.67 | Jan. 8, 2011 | 48,000 | Disposed |
| June 17, 2009 | CVS | Stock Option | Common Stock (22,000) | $19.28 | Jan. 3, 2012 | 22,000 | Disposed |
| June 17, 2009 | CVS | Stock Option | Common Stock (34,000) | $14.96 | Jan. 2, 2012 | 34,000 | Disposed |
| April 1, 2009 | CVS | Stock Option | Common Stock (101,708) | $28.10 | April 1, 2016 | 101,708 | Acquired |
| April 1, 2008 | CVS | Stock Option | Common Stock (86,487) | $41.17 | April 1, 2015 | 86,487 | Acquired |
| Aug. 30, 2007 | CVS | Stock Option | Common Stock (40,000) | $18.66 | March 12, 2008 | 40,000 | Disposed |
| Aug. 30, 2007 | CVS | Stock Option | Common Stock (13,020) | $18.35 | Feb. 27, 2008 | 13,020 | Disposed |
| Aug. 30, 2007 | CVS | Stock Option | Common Stock (54,000) | $12.56 | Jan. 9, 2013 | 54,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 15 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 23, 2007 | CVS | Common Stock | — | Direct |
| Aug. 23, 2007 | CVS | Common Stock (Restricted) | — | Direct |
| Aug. 23, 2007 | CVS | ESOP Preference Stock | 4,307 | Indirect |
| Aug. 23, 2007 | CVS | Phantom Stock Credits→ Common Stock (4,717) | 4,717 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (54,000) | 54,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (34,000) | 34,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (48,000) | 48,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (13,020) | 13,020 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (40,000) | 40,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (22,000) | 22,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (48,000) | 48,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (14,000) | 14,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (64,546) | 64,546 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (24,000) | 24,000 | Direct |
| Aug. 23, 2007 | CVS | Stock Option→ Common Stock (60,484) | 60,484 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $1,200,000 | — | — | — | $3,024,000 | — | $309,699 | $13,001,212 |
| 2014 | $900,000 | — | — | — | $3,915,058 | — | — | $7,686,423 |
| 2012 | $766,667 | — | — | — | $2,835,034 | — | — | $7,863,423 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.